Methyl piperazin-1-ylacetate hydrochloride, 95.0%, 5g

3-Phenyl-4-thioxo-3,4-dihydrophthalazine-1-carboxylic acid, 98%, 5g

1,2-Ethanediamine, N1-[2-(3,4-dichlorophenyl)ethyl]-N1,N2,N2-trimethyl-, hydrobromide (1:2), 50mg

4-[(methylsulfanyl)methyl]benzonitrile, 95%, 100mg

(2E)-1-(2,5-dichlorophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

1-(4-Chlorophenyl)cyclopropane carbonitrile, 95.0%, 5g

1-N-Boc-3-(4-Bromophenoxy)pyrrolidine, 97.0%, 1g

3-(Nitromethyl)oxetan-3-ol, 97%, 10g

(R)-1-(2-(Difluoromethoxy)-4-fluorophenyl)ethan-1-amine, 95%, 100mg

tert-Butyl 3-(cyanomethyl)benzoate, 98%, 500mg

(4R,4'R)-2,2'-(Pentane-3,3-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 250mg

(3-Methylpyrazin-2-yl)methanol, 95.0%, 500mg

Pipeta microlitro monocanal ROTILABO®, 100 a 1000 µl, 1 unidad